BIOCIRCUITS CORP
8-K, 1998-05-20
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: RENAISSANCE CAPITAL PARTNERS LTD, 10-Q, 1998-05-20
Next: BIOCIRCUITS CORP, 10-Q, 1998-05-20



<PAGE>
                                          
                         SECURITIES AND EXCHANGE COMMISSION
                               WASHINGTON, D.C. 20549
                                          
                                          
                                      FORM 8-K
                                          
                                          
                                   CURRENT REPORT
                                          
                      PURSUANT TO SECTION 13 OR 15(d) OF THE 
                          SECURITIES EXCHANGE ACT OF 1934
                                          
                                          
          DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):  MAY 19, 1998
                                          
                                          
                                          
                                          
                              BIOCIRCUITS CORPORATION
               (Exact name of registrant as specified in its charter)
                                          
                                          
                                      DELAWARE
           (State or other jurisdiction of incorporation or organization)


          
                 0-19975                            94-3088884
          (Commission File No.)         (I.R.S. Employer Identification No.)
          

                                          
                              1324 CHESAPEAKE TERRACE
                            SUNNYVALE, CALIFORNIA, 94089
                (Address of principal executive offices and zip code)
                                          
                                          
                                    (408) 745-1961
                (Registrant's telephone number, including area code)
                                          
<PAGE>

ITEM 5.   OTHER MATTERS

          On May 19, 1998, the Company issued a press release announcing that 
          it had exhausted its cash resources, was terminating its business 
          operations and had initiated the process of liquidating its assets.


                                         2
<PAGE>

ITEM 7.  EXHIBITS

Exhibit 1.     Press release dated May 19, 1998


                                          3
<PAGE>

                              BIOCIRCUITS CORPORATION
                                    SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the 
registrant has duly caused this report to be signed on its behalf by the 
undersigned hereunto duly authorized.

                                 BIOCIRCUITS CORPORATION



Date:     May 19, 1998

                                 By: /s/ John Kaiser 
                                     ---------------------------
                                     John Kaiser
                                     President and Chief Executive Officer



                                 By: /s/ James Welch
                                     ---------------------------
                                     James Welch
                                     Vice President and Chief Financial Officer


                                       4

<PAGE>
                                                                      Exhibit 1


                                            Contact:  John Kaiser
                                                      President and CEO
                                                      Biocircuits Corporation
                                                      (408) 752-8706

                                                      James Welch
                                                      Vice President & CFO
                                                      Biocircuits Corporation
                                                      (408) 752-8728

FOR IMMEDIATE RELEASE


                 BIOCIRCUITS ANNOUNCES THAT THE COMPANY HAS 
                 INSUFFICIENT FUNDS TO CONTINUE OPERATIONS
                                          
                                          
SUNNYVALE, CA---MAY 19, 1998---Biocircuits Corporation (Nasdaq: BIOC) today 
announced that the Company has been unable to secure additional financing or 
to arrange a sale or merger and currently has insufficient funds to continue 
operations. Therefore the Company has terminated all employees and ceased all 
ordinary business operations as of close of business on Monday May 18, 1998. 
The Company intends to immediately proceed with the orderly liquidation 
and/or sale of its assets for the benefit of its creditors and shareholders.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission